LIFEVANTAGE CORP Inventory, Finished Goods, Net of Reserves
LIFEVANTAGE CORP (LFVN) had Inventory, Finished Goods, Net of Reserves of $14.58 million as of 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Notes › Inventory › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-05-06
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $14.58M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $15.98M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $17.39M.
- 2025-06-30: Inventory, Finished Goods, Net of Reserves $17.74M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-03-31 | $14.58M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $15.98M 10-Q · filed 2026-02-04 |
| 2025-09-30 | $17.39M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $17.74M 10-Q · filed 2026-05-06 |
| 2025-03-31 | $18.80M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $13.90M 10-Q · filed 2025-02-05 |
| 2024-09-30 | $14.17M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $11.84M 10-Q · filed 2025-05-06 |
| 2024-03-31 | $11.27M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $11.77M 10-Q · filed 2024-01-30 |
| 2023-09-30 | $12.26M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $12.15M 10-Q · filed 2024-05-02 |
| 2023-03-31 | $14.57M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $16.45M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $14.57M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $12.67M 10-Q · filed 2023-05-04 |
| 2022-03-31 | $12.35M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $12.13M 10-Q · filed 2022-02-01 |
| 2021-09-30 | $12.08M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $12.22M 10-Q · filed 2022-05-03 |
| 2021-03-31 | $10.90M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $10.65M 10-Q · filed 2021-02-02 |
| 2020-09-30 | $11.62M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $10.16M 10-Q · filed 2021-04-29 |
| 2020-03-31 | $10.33M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $10.74M 10-Q · filed 2020-01-28 |
| 2019-09-30 | $10.33M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $9.90M 10-Q · filed 2020-05-05 |
| 2019-03-31 | $10.24M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $9.36M 10-Q · filed 2019-02-04 |
| 2018-09-30 | $8.23M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $7.86M 10-Q · filed 2019-05-01 |
| 2018-03-31 | $9.21M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $9.14M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $7.42M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $7.82M 10-Q · filed 2018-05-09 |
| 2017-03-31 | $9.46M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $10.66M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $12.85M 10-Q · filed 2016-12-12 |
| 2016-06-30 | $14.85M 10-Q · filed 2017-05-10 |
| 2016-03-31 | $8.91M 10-Q/A · filed 2016-07-19 |
| 2015-12-31 | $4.46M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $4.28M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $5.78M 10-Q/A · filed 2016-07-19 |
| 2015-03-31 | $7.18M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $8.25M 10-Q · filed 2015-02-04 |
| 2014-09-30 | $6.97M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $4.75M 10-Q · filed 2015-05-06 |
| 2014-03-31 | $5.21M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $6.20M 10-Q · filed 2014-02-06 |
| 2013-09-30 | $6.19M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $5.27M 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |